8-23007627-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5
The NM_015178.3(RHOBTB2):c.1382G>C(p.Arg461Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R461H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_015178.3 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 64Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RHOBTB2 | NM_015178.3 | c.1382G>C | p.Arg461Pro | missense_variant | Exon 5 of 10 | ENST00000251822.7 | NP_055993.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RHOBTB2 | ENST00000251822.7 | c.1382G>C | p.Arg461Pro | missense_variant | Exon 5 of 10 | 1 | NM_015178.3 | ENSP00000251822.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 38
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 64 Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [3Cnet: 0.95 (>=0.6, sensitivity 0.72 and precision 0.9)]. A different missense change at the same codon (p.Arg461His) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000545417 /PMID: 28856709). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg483 amino acid residue in RHOBTB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28856709, 229276004). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RHOBTB2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 483 of the RHOBTB2 protein (p.Arg483Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at